James Paul Scopa, Director at Adverum Biotechnologies, Inc. (ADVM), bought 100,000 shares at $1.35 ($135K) on 2024-02-07, disclosed to the SEC on 2024-02-09.
Open-market purchase of $135k ADVM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| DICE | BUY | 2021-09-16 | $102K | — | Filing → |
| ADVM | BUY | 2020-02-14 | $138K | — | Filing → |
| ADVM | BUY | 2019-05-06 | $134K | — | Filing → |